Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothesis testing in clinical trials.

S B Green1

  • 1Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Hematology/Oncology Clinics of North America
|August 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Monte Carlo Investigation of Methods for Controlling Type I Errors with Specification Searches in Structural Equation Modeling.

Multivariate behavioral research·2016
Same author

How Many Subjects Does It Take To Do A Regression Analysis.

Multivariate behavioral research·2016
Same author

Control of Type I Errors with Multiple Tests of Constraints in Structural Equation Modeling.

Multivariate behavioral research·2016
Same author

Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2006
Same author

Characterization of plant beta-ureidopropionase and functional overexpression in Escherichia coli.

Plant physiology·2001
Same author

Carbohydrate supplementation attenuates muscle glycogen loss during acute bouts of resistance exercise.

International journal of sport nutrition and exercise metabolism·2000
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Clinical trial design requires addressing patient heterogeneity through adequate patient numbers and randomization. Intention-to-treat analysis includes all randomized patients, while subgroup analyses increase spurious result risks.

Area of Science:

  • Clinical trial design and analysis
  • Biostatistics
  • Medical research methodology

Background:

  • Patient heterogeneity presents challenges in clinical trials, including effects of chance and bias.
  • Adequate patient enrollment and randomization are key strategies to mitigate these challenges.

Purpose of the Study:

  • To outline essential considerations for designing and analyzing clinical trials.
  • To discuss methods for addressing patient heterogeneity and potential biases.

Main Methods:

  • Enrollment of adequate patient numbers.
  • Randomization of treatment assignment.
  • Intention-to-treat analysis of outcome data.

Main Results:

  • Randomization and adequate sample size help control for chance and bias.

Related Experiment Videos

  • Intention-to-treat analysis ensures all randomized patients are included in the analysis.
  • Data-derived subgroup analyses increase the risk of spurious findings.

    • Conclusions:

    • Careful consideration of patient heterogeneity, bias, and chance is crucial for robust clinical trial design.
    • Intention-to-treat analysis and appropriate design (e.g., factorial) enhance trial validity and efficiency.